BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Caliway Advances Global Phase 3 Programme For CBL 514 Following U.S. FDA IND Clearance

Asia-Pacific Phase 2 Study CBL-0206 Also Approved by Australia HREC and Taiwan TFDA, Accelerating Global Dual-Track Strategy ...

May 26, 2026 | News

Scribe Therapeutics Gains Australian Clearance To Begin First Human Trial Of STX 1150 For Hypercholesterolemia

Scribe Therapeutics, Inc. (Scribe), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to exte...

May 26, 2026 | News

Ingenia Therapeutics Secures KRX Approval For IPO Amid Advancing TIE2 Targeted Pipeline

Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced that the company has receive...

May 26, 2026 | News

Beckman Coulter Life Sciences Commercialises Echo 650 Plus Series For Next Generation Acoustic Liquid Handling

Beckman Coulter Life Sciences, a Danaher company and global leader in laboratory automation and innovation, has announced the commercial release of the Ech...

May 26, 2026 | News

Nuance Pharma Secures NMPA Clearance For Pivotal Actair® Allergy Trial In China

NMPA Approval Marks Key Milestone in Advancing House Dust Mite Allergy Immunotherapy to Chinese Patients Nuance Pharma announced that the National Medical...

May 25, 2026 | News

Allergan Aesthetics Receives Positive CHMP Opinion For Boey Across Europe

Boey® has received a positive opinion from the CHMP for 30 EU & EEA markets If approved, Boey® has the potenti...

May 25, 2026 | Regulatory

Polpharma Biologics And Tuteur Sign Landmark LATAM Biosimilar Licensing Partnership

Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a...

May 25, 2026 | News

Kivo Launches Headless GxP Architecture To Power AI Native Drug Development Workflows

New open architecture connects AI agents, regulated workflows, and human-authenticated action to Kivo’s GxP-compliant platform. Kivo, the unified do...

May 21, 2026 | News

Samsung Bioepis Launches First Ustekinumab Biosimilar In Japan With NIPRO

Ustekinumab BS 45 mg Syringe for S.C. Injection「NIPRO」 is now available in Japan, after its listing under the National Health Insurance (NHI) Drug ...

May 21, 2026 | News

HistoSonics Secures Taiwan Approval For Edison Histotripsy System

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, announced it has received approval from the Taiwan...

May 21, 2026 | News

HaemaLogiX Opens Phase 1 KOALA Trial Of KMCAR T Cell Therapy For Relapsed Multiple Myeloma

Phase 1 KOALA clinical trial evaluating KMCAR™ T-cell therapy in relapsed/refractory kappa-restricted multiple myeloma now open for patient enrolme...

May 21, 2026 | News

Piramal Pharma Solutions Partners With Botanix Pharmaceuticals To Strengthen Sofdra Supply Chain

Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development ...

May 20, 2026 | News

Piramal Pharma Solutions Partners With Botanix Pharmaceuticals To Strengthen Sofdra Supply Chain

Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development ...

May 20, 2026 | News

Accro Bioscience Secures $50 Million Series C Financing To Advance Immune Disease Pipeline

Financing led by OrbiMed with participation from TCGX, LAV, Cenova Capital and existing investors SCGC and Oriza Proceeds will advance multi-asset ...

May 20, 2026 | News

Stay Connected